Nuwellis, Inc. last reported quarterly results on Aug 13, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $2.0 million (+14.1% year over year) and diluted EPS of -$26.64. It usually reports 42–69 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 11, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Nov 12, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 42–69 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 13, 2026
44 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
2
+14.1%
|
-5
+61.5%
|
-26.64
+98.8%
|
|
May 12, 2026
42 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
2
+26.2%
|
-5
-50.7%
|
-2.19
+92.4%
|
|
Mar 10, 2026
69 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
2
+4.4%
|
-2
-65.0%
|
-1.51
-107.9%
|
|
Nov 12, 2025
43 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
2
-6.3%
|
0
-80.2%
|
0.56
-99.2%
|
|
Aug 14, 2025
45 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
2
-21.4%
|
-13
-62.5%
|
-2,134.19
-169.5%
|
|
May 13, 2025
43 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
2
+2.5%
|
-3
+30.4%
|
-28.93
-20.0%
|
|
Mar 11, 2025
70 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
2
-9.0%
|
-1
+73.4%
|
19.04
+134.7%
|
|
Nov 1, 2024
32 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
2
-1.9%
|
2
+170.0%
|
73.23
+215.7%
|
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NUWE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Eden Prairie, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506492
- Former names
- CHF Solutions, Inc. (until Apr 16, 2021); Sunshine Heart, Inc. (until May 23, 2017)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.